Detalhe da pesquisa
1.
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
N Engl J Med
; 384(4): 325-334, 2021 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33440084
2.
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
Eur Respir J
; 61(6)2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37080567
3.
The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome.
Am J Physiol Lung Cell Mol Physiol
; 315(5): L653-L661, 2018 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30091378
4.
Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies.
Pulm Ther
; 10(1): 85-107, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38184507
5.
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
Pulm Circ
; 12(1): e12012, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35506085
6.
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Pulm Circ
; 12(2): e12055, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35514769
7.
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Pulm Circ
; 12(2): e12063, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35514770
8.
Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery.
Eur Respir Rev
; 30(162)2021 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34937705
9.
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily.
Pulm Circ
; 11(4): 20458940211052228, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34733493
10.
A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil.
Pulm Circ
; 11(1): 2045894021998203, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33738096
11.
Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population.
BMJ Case Rep
; 20182018 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29866667